|
Report Date : |
01.02.2014 |
IDENTIFICATION DETAILS
|
Name : |
SELMORE PHARMACEUTICALS (PVT.) LTD. (SPPL) |
|
|
|
|
Registered Office : |
SPL House, 82, R-1, M.A Johar Town, Lahore |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Date of Incorporation : |
08.12.1998 |
|
|
|
|
Com. Reg. No.: |
0039705 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacturing of human and veterinary pharmaceutical products and also
importer of raw material. |
|
|
|
|
No. of Employees : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 01, 2013
|
Country Name |
Previous Rating (30.09.2013) |
Current Rating (01.12.2013) |
|
Pakistan |
B2 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
PAKISTAN - ECONOMIC OVERVIEW
Decades of internal political
disputes and low levels of foreign investment have led to slow growth and
underdevelopment in Pakistan. Agriculture accounts for more than one-fifth of
output and two-fifths of employment. Textiles account for most of Pakistan's
export earnings, and Pakistan's failure to expand a viable export base for
other manufactures has left the country vulnerable to shifts in world demand.
Official unemployment is under 6%, but this fails to capture the true picture,
because much of the economy is informal and underemployment remains high. Over
the past few years, low growth and high inflation, led by a spurt in food
prices, have increased the amount of poverty - the UN Human Development Report
estimated poverty in 2011 at almost 50% of the population. Inflation has worsened
the situation, climbing from 7.7% in 2007 to almost 12% for 2011, before
declining to 10% in 2012. As a result of political and economic instability,
the Pakistani rupee has depreciated more than 40% since 2007. The government
agreed to an International Monetary Fund Standby Arrangement in November 2008
in response to a balance of payments crisis. Although the economy has
stabilized since the crisis, it has failed to recover. Foreign investment has
not returned, due to investor concerns related to governance, energy, security,
and a slow-down in the global economy. Remittances from overseas workers,
averaging about $1 billion a month since March 2011, remain a bright spot for
Pakistan. However, after a small current account surplus in fiscal year 2011
(July 2010/June 2011), Pakistan's current account turned to deficit in fiscal
year 2012, spurred by higher prices for imported oil and lower prices for
exported cotton. Pakistan remains stuck in a low-income, low-growth trap, with
growth averaging about 3% per year from 2008 to 2012. Pakistan must address
long standing issues related to government revenues and energy production in
order to spur the amount of economic growth that will be necessary to employ
its growing and rapidly urbanizing population, more than half of which is under
22. Other long term challenges include expanding investment in education and
healthcare, adapting to the effects of climate change and natural disasters,
and reducing dependence on foreign donors.
|
Source
: CIA |
Selmore Pharmaceuticals (Pvt.) Ltd. (SPPL)
|
Business Name |
Business Name: Selmore Pharmaceuticals (Pvt.) Ltd. (SPPL) Inquiry Name: Seimore Pharmaceutical (Pvt.) Ltd. |
|
Address |
Head Office Address: SPL House, 82, R-1, M.A Johar Town, Lahore-Pakistan Factory Address: 36-KM Multan Road Lahore, Pakistan |
|
Telephone |
042-35291774-5 |
|
Fax |
042-35291776 |
|
Mobile |
+92-345-4016016 |
|
Email |
|
|
Website |
|
|
Business
activities |
Manufacturing of human and veterinary pharmaceutical products and also
importer of raw material. |
|
CRO Registration
Number |
0039705 |
|
Date of
Registration |
December 08, 1998 |
Other registry
& certification details:
|
Current Legal
Form |
Private Limited Company |
|
National Tax
Registration Number |
1525643-0 |
|
Date of Registration |
March 22, 2003 |
|
GST Registration
Number |
0397999983964 |
|
Date of
Registration & Expiry |
October 30, 2000 |
|
Chamber of
Commerce & Industry |
Lahore Chamber of Commerce and Industry |
|
Date of
Registration |
Undetermined |
|
ISO Certification |
ISO 9001 & 14001 |
|
Other
certifications |
None |
|
Type |
No. of Shares |
Par Value |
Total Value |
|
Authorized |
Undetermined |
||
|
Issued,
Subscribed & Paid-Up |
|||
|
Who started |
Undetermined |
|
When started |
1998 |
|
Change in
management |
None |
|
Year of change |
N/A |
|
Change in legal
status |
None |
|
Year of change |
N/A |
|
Change in
business name |
None |
|
Year of change |
N/A |
|
Name |
Number of Shares |
Nationality |
Appointment Date (Last) |
|
Not Disclosed |
|||
|
Name |
Position
in organization |
Qualification |
Years in employment |
|
Not Disclosed |
|||
|
Statutory
offices |
|
|
Statutory Auditors |
Not provided.
|
|
Legal Advisory Services |
Not provided. |
|
Bank name |
Approved financing limits |
|
Not Disclosed |
|
The primary focus of SPPL is Manufacturing of Human and Veterinary
Pharmaceutical product.
Veterinary Products
|
Product Name |
Composition |
Medication |
Pack Size |
|
||
|
Analgesic Meloxi-10 Injection |
Each ml
contains: Meloxicam 10mg |
Large Animals,
Pets |
10ml, 20ml,
50ml, 100ml |
|
||
|
Melocam-20 Injection |
Each ml contains:
Meloxicam 20mg |
Large Animals,
Pets |
10ml, 20ml,
30ml, 50ml, 100ml |
|
||
|
Analgesic/NSAID Ketoject Injection |
Each ml
Contains: Ketoprofen 100mg |
Large Animals |
10ml, 20ml,
50ml, 100ml |
|
||
|
Loxin Injection |
Each ml Contains:
Flunixin Meglumine 50mg |
Large Animals |
10ml, 20ml, 50ml |
|
||
|
Anthelmintic/Ectoparasite Actimec Injection |
Each 100ml
Contains: Ivermectin 1g |
Large Animals,
Poultry |
10ml, 20ml,
50ml, 100ml |
|
||
|
Actimec Plus Injection |
Each 100ml
Contains: Ivermectin 1g, Clorsulon 10g |
Large Animals |
10ml, 50ml,
100ml |
|
||
|
Antibacterial/Analgesic Oxyfen-LA Injection |
Each ml
contains: Oxytetracycline 20%, Ketoprofen 3% |
Large Animals |
10ml, 20ml,
50ml, 100ml |
|
||
|
Antibacterial/Antiinflammatory Cortisel Spray |
Each ml
contains: Oxytetracycline HCl(USP) 5mg, Hydrocortisone(BP) 1.6mg |
Large Animals |
150ml, 250ml |
|
||
|
Antibacterial/Antimycoplasma Hi-Resp Powder |
Each KG
contains: Tylosin Tartrate100gm, Doxycycline HCI 200gm, Colistine Sulphate
500MIU, Phenlbutazone 12gm, Bromhexine 5gm |
Poultry |
100gm, 250gm,
500gm 1000gm |
|
||
|
Tydoxin WS Powder |
Each gm
Contains: Tylosin Tartrate 100mg, Doxycycline HCI 200mg |
Poultry |
100g, 250g,
500g, 1 Kg |
|
||
|
Anticoccidial Coxiril Plus Solution |
Each ml
Contains: Toltrazuril 25mg, Vitamin A 2.5mg, Vitamin K3 5.0mg |
Poultry |
100ml, 250ml,
500ml 1000ml |
|
||
|
Coxiril Solution |
Each ml
Contains: Toltrazuril 25mg |
Poultry |
100ml, 250ml,
500ml, 1 Liter |
|
||
|
Coxivit Powder |
Each 500gm
contains: 2,4, diamino-5, Veratrylpyrimidine 25gm, Sulphabenzpyrazine 100gm,
Vitamin A 1.250 MIU., Menadione Sulphite Sodium (Vitamin K3) 2.50gm |
Poultry |
100gm, 250gm,
500gm 1000gm |
|
||
|
Darvinox Plus Solution |
Each ml
contains: Sulfaquinoxaline 80mg, Sulfadimethoxine 20mg, Diaveridine 20mg |
Poultry |
100ml, 250ml,
500ml, 1000ml |
|
||
|
Antidiarroheal Scour-x Oral Suspension |
Each 100ml Contains:
Sulphadiazine 3.550g, Sulphadimidine 2.840g, Neomycin Sulphate 0.180,
Hyoscine Methylbromide 0.004g, Pactin 0.710g, Kaolin 10.330g Vitamin B-1
0.015g, Vitamin B-2 0.022gm |
Large Animals |
100ml, 250ml,
500ml, 1 Liter |
|
||
|
Antiflautulent Blotnil Oral Liquid |
Contains:
Polyoxyethylene Olic Acid Triglyceride 100% |
Large Animals |
10ml |
|
||
|
Antiprotozoal Coumafos-50Wettable Powder |
Each gm
Contains: Coumaphos 500mg |
Large Animals |
15g, 50g, 100g |
|
||
|
Imipro Injection |
Each ml Contains:
Imidocarb Dipropionate 120mg |
Large Animals
(Cow/Buffalo) |
10ml, 50ml,
100ml |
|
||
|
Parvon Injection |
Each ml
Contains: Buparvaquone 50mg |
Cow, Buffalo |
10ml, 20ml,
40ml, 100ml |
|
||
|
Pronil Injection |
Each ml Contians:
Diminazine Aceturate 105.00mg, Antipyrine 131.00mg |
Large Animals |
10ml, 50ml |
|
||
|
Antipyretic/Analgesic Pyrosel Injection |
Each ml
contains: Methampyrone 200mg, Aminopyrine 50mg, Caffeine 20mg,
Chlorpheniramine Maleate 2mg |
Large Animals,
Medium Animals, Small Animals |
10ml, 30ml,
50ml, 100ml |
|
||
|
Antisorra Quina-CS Injection |
Each vial
contains: Quinapyramine Sulphate 1.5gm, Quinapyramine Chloride 1.0gm |
Cow / Buffalo |
2.5gm Vial |
|
||
|
Antistress/Antipyretic Sali - C Powder |
Each gm
Contains: Acetyl Salicylic Acid 67mg, Vitamin C 200mg |
Poultry |
100g, 500g, 1 KG |
|
||
|
Antitod/Antihistamin Atrovet Injection |
Each ml
Contains: Atropine Sulphate 1mg |
Large Animals |
10ml, 25ml, 50ml |
|
||
|
Anti-Toxin Betatox Powder |
Each kg
Contains: Sodium Benzoate 500gm, Ethanol Beta Amino Phosphoric Acid 100gm,
Vitamin A 10MIU, Vitamin E 2.5gm, Vitamin K3 1.0gm, Vitamin C 2.5gm |
Poultry |
100gm, 250gm,
500gm 1000gm |
|
||
|
Digestive Tonic Gestone Oral Powder |
Each gm
Contains: Propionic acid calcium 250mg, Propionic acid sodium 400mg,
Acetanilide150mg, Magnesium Oxide 125mg, Iron II Sulphate 0.40mg, Zinc
Sulphate 0.10mg, Magnesium Sulphate 0.20mg, Copper Sulphate 0.45mg, Cobalt
Sulphate 0.40mg, Sodium Molybdate 0.10mg, Sodium Chloride 20mg |
Large Animals |
25gm, 50gm,
100gm, 1 KG |
|
||
|
Disinfactant/Ectoparasite Delta - 25 Solution |
Each ml
Contains: Deltamethrin 2.5% |
Large Animals,
Poultry |
10ml, 100ml,
250ml, 500ml, 1 Liter |
|
||
|
Ectoparasitic Ectofone Powder |
Trichlorophone
98% |
Large Animals |
100gm x5's,
250gm, 500gm, 1000gm |
|
||
|
Flusher Nephrex Oral Powder |
Each 100gm
Contains: Methenamine 95g, Vitamin B-1 0.80g, Vitamin B-2 0.92g, Vitamin K-3
0.20g |
Poultry |
250g, 500g, 1 KG |
|
||
|
Rinosel Powder |
Each gm
contains: Hexamethylene Tetramine 955mg, Riboflavin 10mg, Calcium
Pantothenate 5mg, Nicotinamide 25mg |
Poultry |
100gm, 250gm,
500gm 1000gm |
|
||
|
Hormone Pregtone Injection |
Each ml
contains: Progesterone 25mg |
Large Animals |
2ml, 5ml, 10ml |
|
||
|
Prostenol Injection |
Each ml
Contains: Cloprostenol Sodium 263mcg equivalent to 250mcg Cloprostenol |
Cows, Mares,
Bitches, etc |
2ml, 10ml |
|
||
|
Serilin Injection |
Each ml
contains: Lecirelin 25mcg |
Cows, Mares,
Bitches, etc |
2ml x5's, 10ml
x5's |
|
||
|
Liver Tonic Hepasel Injection |
Each ml
Contains: Phenoxy-2 methyl-2 propionic acid 100mg |
Large Animals |
30ml, 50ml,
100ml |
|
||
|
Restorative/Immune Booster Supertone Solution |
Each ml contains:
Vitamin E 200mg, Sorbitol 50mg, Choline Chloride 50mg, Selenium 2.3mg, Zinc
4mg |
Poultry |
100ml, 250ml,
500ml, 1000ml |
|
||
|
Restorative/Multivitamin Soluvit Super Powder |
Each gm Contains:
Vitamin A 20,000IU, Vitamin 20mg, Vitamin D 4000IU, Vitamin B6 6mg, Vitamin E
8mg, Vitamin B-12 30mcg, Vitamin K 9mg, Folic Acid 2mg, Vitamin C 10mg,
Nicotinic Acid 100mg, Vitamin B1 1.25mg, Calcium Pantothenate 30mg |
Poultry |
100gm, 250gm,
500gm 1000gm |
|
||
|
Steroid Penacort Injection |
Each 100ml
Contains: Prednisolone as Acetate 0.750g, Dexamethasone 0.25g |
Large Animals,
Pets |
10ml, 30ml, 50ml |
|||
|
Solomin Injection |
Each ml
contains: Prednisolone 10mg, Chlorpheniramine Maleate 4mg |
Large Animals |
10ml, 20ml,
50ml, 100ml |
|||
|
Solopred Injection |
Each ml
Contains: Prednisolone 25mg |
Large Animals |
50ml, 100ml |
|||
Human Products
|
Product Name |
Composition |
Medication |
Pack Size |
|
Anthelmintic |
Each 5 ml
contains: Albendazole 100mg |
For the
treatment of Protozoa land worms infections |
10ml |
|
Amoebicides |
Each 5ml
contains: di-Hydroxylquinoline 200mg,
Metronidazole Benzoate 321.5 eq to Metronidazole 200mg |
For the
treatment of protozoal and bacterial infections |
60ml |
|
Analgesic |
Each Tablet
contains: Paracetamol 500 mg, Caffeine 65 mg |
For the relief from
Headache, migraine, muscle pains, neuralgia |
10x10's |
|
Analgesic / Anti-histamine |
Each Tablet contains:
Paracetamol 500 mg, Pseudoephedrine Hcl 60 mg, Chlorpheniramine Maleate 4mg |
For the relief
of sinus congestion and pain |
100's |
|
Anti-Asthmatic |
Each Tablet
contains: Montelukast (as Sodium) 10mg |
For the
treatment of asthamatic and bronchospasm patients |
14's |
|
Each Tablet contains:
Montelukast (as Sodium) 5 mg |
For the
treatment of asthamatic and bronchospasm patients |
14's |
|
|
Anti-Convulsant |
Each Capsule
Contains: Gabapentin .100 mg |
For the
treatment of partial seizures, neuropathic pains |
10 's |
|
Each Capsule
Contains: Gabapentin .300 mg |
For the treatment
of partial seizures, neuropathic pains |
10 's |
|
|
Anti-Epileptics |
Each ml
contains: Levetiracetam 100mg |
For the
treatment of epilepsy |
120ml |
|
Anti-Fungal |
Each tablet
contains: Clotrimazole 500mg |
For the
treatment of Fungal infections |
1's |
|
Each Capsule
contains: Fluconazole 150mg |
For the
treatment of Fungal infections |
1's |
|
|
Anti-Malarial |
Each Tablet
contains: Artemether 20 mg, Lumefantrine 120 mg |
For the
treatment of Malaria |
1x16 's |
|
Anti-Platelet |
Each Tablet
contains: Clopidogrel (as Sulphate) 75 mg |
For the
treatments Atherothrombotic indications |
10's |
|
Imports from |
China, India, Taiwan, Korea |
|
Importing terms |
LC Basis. |
|
Local (%) |
70% |
|
Local buying
terms |
Cash & 30 days credit. |
|
Exports to |
Korea, India, Afghanistan, Saudia Arabia |
|
Exporting terms |
DA/LC Basis |
|
Local (%) |
90% |
|
Local selling
terms |
Cash & 30 days credit. |
|
Nature of employment |
Current Year |
Previous Year |
|
All Staff |
Undetermined |
Undetermined |
|
Total |
Undetermined |
|
|
Head office
Address Owned / Rented Area (approx) |
SPL House, 82, R-1, M.A Johar Town, Lahore-Pakistan Details not provided. |
|
Factory Address Owned / Rented Area (approx) |
36-KM Multan Road Lahore, Pakistan Details not provided. |
We contacted two vendors and two customers of SPPL, all the feedback was
found satisfactory, the vendors commented they have been working with the
client for some time now and they have never faced any issues such as stuck ups
or delays and wish to continue the business relationship in future likewise the
customers also gave positive feedback and commented that they have never faced
any issues such as delays in delivery or anything. We did not came across any
negative comments or issues regarding SPPL.
|
Business Name |
City |
Line of Business |
Percentile of Shareholding |
|
Not Disclosed |
|||
BRIEF INTRODUCTION
Selmore
Pharmaceuticals is a unique site where human and veterinary pharmaceutical products
are produced. An ISO certified and cGMP compliant company, Selmore
Pharmaceuticals strives hard to bring Health and Happiness into the lives of
millions everyday. Our continuous efforts and dedications towards quality
improvement and customer satisfaction turned out to be a leading pharmaceutical
company within a very short time span.
We
are 1st National Veterinary Pharmaceutical certified on ISO 9001 & 14001 by
SGS and our products are manufactured strictly conforming to cGMP and local
regulatory requirements.
QUALITY AND
ENVIRONMENTAL POLICY
Selmore
Pharmaceuticals (Pvt) Ltd. is dedicated towards manufacturing high quality
pharmaceutical products and recognize the discipline of quality and
environmental management as an integral part of its management function. We are
conscious of the impact on environment from manufacturing operations and bound
to implement such measures to eliminate as much as possible any negative impact
on environment from our activities, therefore we are committed to:
DIVERSITY &
INCLUSION
Our success depends on the understanding of needs of our valued
customers all around the world. That is why, we work hard to attract and hire
talented individuals for every possible perspective. At Selmore
Pharmaceuticals, diversity and inclusions are fundamentals of doing things. We
understand that our customers are of different fields which drives the projects
we work on and the goals we set. This commitment to diversity has been key to
our success.
The role of Selmore's diversity and inclusion is rapidly becoming an important
part of overall business strategy to increase performance, productivity and
customer satisfaction.
SALES AND MARKETING
Sales & Marketing of AHD(Animal Health Division) comprises of three
groups. Experienced & self motivated sales team is working tirelessly for
the awareness of our premium products nationally. Activities for awareness
among prescribers, practitioners & end users (farmers) is our prime
objective, via” Meetings” & “Deworming Programs”. A very strong network of
experienced & effective distributors nationally, is Selmore's Strength.
Product Development Department is also working keenly for the identification of
new & viable products and their development. This is truly a “TEAM” working
with “SMART” objectives. Selmore is proud to have such “contributing” Sales
& Marketing Network
EXPORTS
A continuous process of innovation, research and development at Selmore
enables to offer effective solutions for various health care challenges
worldwide, with products and services that are well focused, within the
customer's reach and contribute to improved health care of the people and
animal globally. Selmore is engaged to enhance the manufacturing facilities in
order to provide the health care to international clients as the Selmore
believes that Corporate Social Responsibility is fundamental to earning and
deepening the trust of the international clients it serves, an integral part of
its commitment to improve human and animal lives.
Export Department's team is completely geared for it in terms of
technical capabilities, regulatory compliances, cost advantages and
geographical reach.
"Selmore is 1st pharmaceutical company exporting its products to South
Korea and India."
FOREIGN COLLABORATIONS
In 2011 Selmore Pharmaceuticals upgraded its Portfolio by Acquiring the
Status of Sole Agents for Pakistan for one of the Best veterinary Companies of
Spain namely Laboratories Syva.
Syva hold the portfolio of one of the leading Veterinary Pharmaceutical Company
of Europe and Selmore is proudly marketing its products in Pakistan.
Major Products includes Vaccines and Antibiotics.
PRODUCTION &
SECTIONS
At the plant the veterinary health division is producing quality
products according to the GMP standards to fulfill the requirement of local and
export market. Plant is fully equipped with all necessary manufacturing
facilities and machines. The objective of the selmore pharmaceuticals is to
provide the quality products at affordable price with maximum efficacy. We are
continually improving our materials, processes, equipment and human resources.
Since the start of our production some of our products enjoy leadership and
dominates the veterinary market.
Have following section in veterinary
health division.
QUALITY CONTROL &
MICROBIOLOGY LABORATORIES
Quality Control Laboratory is always considered the back bone of a
Company. It is situated on the first floor of plant and is equipped with latest
HPLC, Spectrophotometer, Stability Chambers in short all the required
instrumentation for maintain quality of international standards. In its future
planning the Company is expending the quality by addition of FTIR, Double beam
spectrophotometer etc to check in-process and post production quality of
medicines. Microbiological Laboratory which is a subsidiary of QC Laboratory
has separate sterile area, media preparation room, incubation area.
A separate sample keeping room is provide to Quality control for storage
of already dispatched batches to market so that post production stability
studies can be conducted
RESEARCH &
DEVELOPMENT PROCESS
Research & development section is there to meet all the pre and post
marketing studies, stability, efficacy etc. the department is fully operational
for developing new line of molecule to be introduces in the range. Special
measures are taken to check the efficacy of medicine after market dispatches.
Special arrangements are there for close intact with marketing team to check
the ongoing field trials & complaint handlings.
The contact person decline to share financial information.
|
Contact person |
Mr. Muhammad Sajjad |
|
Position |
Export Manager |
|
Comments |
The contact person provided some information but was reluctant to provide
complete business information without knowing the details of the inquirer. |
|
Observations |
·
The company is considered as one the leading
companies in its line on business. ·
SPPL is working with leading companies of
Pakistan. ·
All the customer gave positive comments about
SPPL. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.48 |
|
|
1 |
Rs.102.95 |
|
Euro |
1 |
Rs.84.60 |
INFORMATION DETAILS
|
Report Prepared
by : |
NIT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.